Electromed Inc
AMEX:ELMD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/GP
Enterprise Value to Gross Profit (EV/GP) ratio compares a company`s total enterprise value to its gross profit. It shows how much investors are paying for each dollar of the company`s gross profit, including both equity and debt.
Enterprise Value to Gross Profit (EV/GP) ratio compares a company`s total enterprise value to its gross profit. It shows how much investors are paying for each dollar of the company`s gross profit, including both equity and debt.
Valuation Scenarios
If EV/GP returns to its 3-Year Average (3.2), the stock would be worth $22.61 (10% downside from current price).
| Scenario | EV/GP Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 3.6 | $25.1 |
0%
|
| 3-Year Average | 3.2 | $22.61 |
-10%
|
| 5-Year Average | 3.1 | $21.85 |
-13%
|
| Industry Average | 5.2 | $36.17 |
+44%
|
| Country Average | 6.5 | $45.73 |
+82%
|
Forward EV/GP
Today’s price vs future gross profit
Peer Comparison
| Market Cap | EV/GP | P/E | ||||
|---|---|---|---|---|---|---|
| US |
E
|
Electromed Inc
AMEX:ELMD
|
207.8m USD | 3.6 | 23.1 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
161.2B USD | 23.4 | 56.4 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
158.6B USD | 6.3 | 25.3 | |
| US |
|
Stryker Corp
NYSE:SYK
|
120.5B USD | 8.1 | 37.1 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
101.9B USD | 5.2 | 22.1 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
84.8B USD | 6.6 | 23.8 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
47.2B USD | 8.9 | 43 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
44.1B USD | 16.7 | 41.7 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
38.3B EUR | 5.1 | 18.1 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
41.4B USD | 5.7 | 23.5 | |
| US |
|
Resmed Inc
NYSE:RMD
|
30.9B USD | 9.1 | 20.8 |
Market Distribution
| Min | 0 |
| 30th Percentile | 4.2 |
| Median | 6.5 |
| 70th Percentile | 10.6 |
| Max | 1 764 211.7 |
Other Multiples
Electromed Inc
Glance View
Electromed, Inc. engages in the development, manufacture, marketing, and sale of medical equipment. The company is headquartered in New Prague, Minnesota and currently employs 156 full-time employees. The company went IPO on 2010-08-13. The firm applies High Frequency Chest Wall Oscillation (HFCWO) technologies in pulmonary care for patients of all ages. The company markets SmartVest Airway Clearance System (SmartVest System) which includes SmartVest SQL and SV2100 and related products, to patients with compromised pulmonary function. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe airway clearance therapy. The SmartVest SQL is smaller, quieter and lighter with programmability and ease of use. The company offers SmartVest SQL with SmartVest Connect wireless technology. The SmartVest Connect app allows patients and healthcare teams to track therapy in real-time and collaborate on care decisions to improve therapy adherence and patient outcomes. The company also offers single patient use (SPU) SmartVest and SmartVest Wrap to health care providers.
